Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination

Resource: Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination

These interim considerations provide information on preparing for the initial assessment and management of anaphylaxis following COVID-19 vaccination.

Source: CDC
Topic(s): Vaccination
Audience(s): Clinicians
Format: Webpage
Publication Date: February 10, 2021

Page last reviewed August 2022

Page originally created August 2022

Internet Citation: Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination. Content last reviewed August 2022. Agency for Healthcare Research and Quality, Rockville, MD.
https://www.ahrq.gov/nursing-home/resources/interim-considerations.html

Browse Topics

Topics A-Z

Priority Populations

Programs

Research

Publications & Products

Research Findings & Reports

National Healthcare Quality and Disparities Report

Data & Analytics

Tools

Funding & Grants

Notice of Funding Opportunities

Research Policies

Funding Priorities

Training & Education Funding

Grant Application, Review & Award Process

Post-Award Grant Management

Contracts

AHRQ Grants by State

PCOR

News

Newsroom

Blog

Newsletter

Events

About

About AHRQ

Organization & Contacts

SHARE:

Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination